Co-occurring genomic alterations in non-small-cell lung cancer

Co-occurring genomic alterations in non-small-cell lung cancer

Comprehensive genomic profile of Chinese lung cancer patients and

Comprehensive genomic profiling of Finnish lung adenocarcinoma cohort reveals high clinical actionability and SMARCA4 altered tumors with variable histology and poor prognosis - ScienceDirect

Precision treatment for metastatic non–small cell lung cancer: A

Optimal therapy for concomitant EGFR and TP53 mutated non-small

Overall survival in patients with advanced non-small cell lung cancer with KRAS G12C mutation with or without STK11 and/or KEAP1 mutations in a real-world setting, BMC Cancer

Integrative analysis of a large real-world cohort of small cell

Cancer genome and tumor microenvironment: Reciprocal crosstalk shapes lung cancer plasticity

Current Oncology, Free Full-Text

Cancers, Free Full-Text

Essential thrombocythemia (ET) – MPN Research Foundation

Microbes et cancers Éditions Odile Jacob

Sophrologie et Cancer - Manuel pratique - Livre et ebook Thérapies complémentaires de Catherine Aliotta - Dunod

Baisse des plaquettes et cancer. Thrombopénie causes et taux

YAP and endothelin-1 signaling: an emerging alliance in cancer